Rayence

228850 · KOSDAQ · ₩228850 · 레이언스

₩8,150▲ ₩160 (2.00%)End-of-day · Oct 27, 2026 · End-of-day prices.
Trade
Alert me
Price · 1Y +45.28%
Market cap
₩135B
Enterprise value
−₩12B
P/E
32.3×
P/B
0.6×
Dividend yield
0.0%
ROE
1.7%
Net margin
3.2%

Trailing 12 months from filed financial statements, as of H1 2026. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.

52-week range−6.9% from the high

₩4,835Today: ₩7,880 – ₩8,150₩8,750

Returns

  • 1W−1.1%
  • 1M+3.0%
  • 3M+38.1%
  • 6M+32.3%
  • YTD+56.7%
  • 1Y+45.3%
Volume today
17,358
0.3× the 20-day average
Traded today
₩139M
Listed shares
16,591,014
EPS (12 months)
₩253
Earnings yield 3.1%

Signals

30Quiet
  • BuzzQuietBuzz 30 of 100 (50 is a normal day for this stock).
  • MomentumFlat3.3% over the last month; the price is below its 20-day average.

Signals describe activity, not recommendations. Not financial advice.

Rayence stock overview

Rayence (레이언스, KRX: 228850) is listed on KOSDAQ, in the Medical & precision devices sector. , Ltd. Its shares closed at ₩8,150 on Oct 27, 2026, up 2.00% on the day, giving it a market value of ₩135B.

Key facts

Market cap
₩135B
Sector
Medical & precision devices
Latest price change
+2.00%
As of
Oct 27, 2026
Main business
, Ltd.

Quick answers about Rayence

What does Rayence do?
, Ltd. develops, manufactures and sells digital X-ray detectors, including TFT and CMOS detectors and bendable intraoral (I/O) sensors, for medical, dental, veterinary and industrial use. The company also develops and sells X-ray imaging software for both still and moving images.
What is the market cap of Rayence?
The market capitalisation of Rayence was ₩135B at the close on Oct 27, 2026.
Who are the largest shareholders of Rayence?
According to the latest official filings, the largest reported holders are National Pension Service (0.62%, as of Dec 31, 2025); Acadian Emerging Markets Portfolio (0.10%, as of Jul 31, 2026); Strategic Advisers Emerging Markets Fund (0.07%, as of May 31, 2026).
When is the next earnings report from Rayence?
Korean companies rarely announce results dates in advance. Based on when Rayence filed the same report in past years, its next 3q results is expected around Nov 14, 2026.
Does the National Pension Service own Rayence?
Yes. The National Pension Service held 0.62% of Rayence shares as of Dec 31, 2025.

Company profile

Raionence Co., Ltd. develops, manufactures and sells digital X-ray detectors, including TFT and CMOS detectors and bendable intraoral (I/O) sensors, for medical, dental, veterinary and industrial use. The company also develops and sells X-ray imaging software for both still and moving images. Through subsidiaries such as Ourien and Ourien Pharm, it has expanded into the veterinary medical market, and it operates in Korea, Mexico and the United States.

Written by AI from the company's latest annual report.

Korean name
레이언스
CEO
서영권
Founded
May 2011
Listed
Apr 2016
Listed shares
16,591,014
Fiscal year ends
Month 12

Similar companies

Recent news

News · Money Today·

Laonce posts ₩13.1B in semiconductor AXI detector sales in H1 alone

Predicted impact: Low· Actual: +6.9% vs sector, volume 0.4× normal (5 trading days)

Semiconductor detector sales of ₩13.1B in H1; small relative to a ₩135B market value.

Recent filings

See all

Titles in Korean until English translations are added.

Also known as: Rayence / 레이언스 / 228850 / KRX:228850

Source: KRX statistical information